Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Miller, R. Hays (2000)
Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications.The AIDS reader, 10 3
P. Carrieri, Valérie Cailleton, V. Moing, B. Spire, P. Dellamonica, E. Bouvet, F. Raffi, V. Journot, J. Moatti (2001)
The Dynamic of Adherence to Highly Active Antiretroviral Therapy: Results From the French National APROCO CohortJAIDS Journal of Acquired Immune Deficiency Syndromes, 28
Blake Max, Blake Max, R. Sherer (2000)
Management of the adverse effects of antiretroviral therapy and medication adherence.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 30 Suppl 2
MD Carpenter, MD Cooper, MD Fischl, MD Gatell, MA Gazzard, MD Hammer, MD Hirsch, MD Jacobsen, BS Katzenstein, MD Montaner, MD Richman, M. Saag, MD Schechter, PhD Schooley, MD Thompson, MD Vella, MD Yeni, MD Volberding, MD CharlesC.J.Car-penter (2000)
Antiretroviral Therapy in Adults Updated Recommendations of the International AIDS Society–USA Panel
Gayle Newshan, Brian Taylor, Richard Gold (1998)
Sexual functioning in ambulatory men with HIV/AIDSInternational Journal of STD and AIDS, 9
J. Miró, A. Antela, J. Arrizabalaga, B. Clotet, J. Gatell, L. Guerra, J. Iribarren, F. Laguna, S. Moreno, F. Parras, R. Rubio, J. Santamaría, P. Viciana (2000)
[Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)].Enfermedades infecciosas y microbiologia clinica, 18 8
PT Nieuwkerk, EH Gisolf, R Colebunders, AW Wu, SA Danner, MA. Sprangers (2000)
Quality of life in asymptomatic-and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study GroupAIDS, 14
J De la Fuente, A Ocampo, C. Cadarso-Suárez (2002)
El reto de la adherencia al tratamiento antirretroviral
W. Schrooten, R. Colebunders, M. Youle, G. Molenberghs, N. Dedes, G. Koitz, R. Finazzi, I. Mey, E. Florence, C. Dreezen (2001)
Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatmentAIDS, 15
Xavier Badiaa, Daniel Podzamczerb, Margarida Garciaa, C. López-Lavid, Ezequiel Consigliob (1999)
A randomized study comparing instruments for measuring health-related quality of life in _HIV-infected patientsAIDS, 13
K. Roberts, P. Volberding (1999)
Adherence communication: a qualitative analysis of physician-patient dialogue.AIDS, 13 13
B Gazzard, G. Moyle (1998)
1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Writing CommitteeLancet, 352
A. Miners, C. Sabin, A. Mocroft, M. Youle, M. Fisher, Margaret Johnson (2001)
Health-Related Quality of Life in Individuals Infected with HIV in the Era of HAARTHIV Clinical Trials, 2
JM Miro, A Antela, J Arrizabalaga (2000)
Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II) Grupo de Estudio de SIDA (GESIDA) y por Consejo Asesor Clínico (CAC) de la Secretaria Plan NacionalEnferm Infecc Microbiol Clin, 18
V. Gordillo, J. Amo, V. Soriano, J. González-Lahoz (1999)
Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.AIDS, 13 13
E Carballo, C. Cadarso-Suárez (2002)
Calidad de vida relacionada con la salud en pacientes sometidos a terapia antirretroviral
F. Palella, K. Delaney, A. Moorman, M. Loveless, J. Fuhrer, G. Satten, D. Aschman, S. Holmberg (1998)
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.The New England journal of medicine, 338 13
X. Badia, D. Podzamczer, A. Casado, C. López-Lavid, Margarida García (2000)
Evaluating changes in health status in HIV-infected patients: Medical Outcomes Study-HIV and Multidimensional Quality of Life-HIV quality of life questionnairesAIDS, 14
H Knobel, C Codina, JM Miro (2000)
The recommendations of GESIDA/SEFH/PNS for improving adherence to antiretroviral treatment. AIDS Study Group of the Spanish Society of Hospital Pharmacy and the National Plan on AIDS of the Minister of Health and ConsumersEnferm Infecc Microbiol Clin, 18
G. Pialoux, F. Raffi, F. Brun-vezinet, V. Meiffrédy, P. Flandre, J. Gastaut, P. Dellamonica, P. Yeni, J. Delfraissy, J. Aboulker (1998)
A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.The New England journal of medicine, 339 18
D. Paterson, S. Swindells, Jeffrey Mohr, M. Brester, E. Vergis, C. Squier, M. Wagener, Nina Singh (2000)
Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 133
A. Wu (2000)
Quality of life assessment comes of age in the era of highly active antiretroviral therapy.AIDS, 14 10
D. Descamps, P. Flandre, V. Calvez, G. Peytavin, V. Meiffrédy, G. Collin, C. Delaugerre, Sandrine Robert-Delmas, B. Bazin, J. Aboulker, G. Pialoux, F. Raffi, F. Brun-vezinet (2000)
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).JAMA, 283 2
P. Ganz, C. Schag, B. Kahn, L. Petersen (1994)
Assessing the quality of life of HIV infected persons: Clinical and descriptive information from studies with the hopesPsychology & Health, 9
Peter Tsasis (2001)
Adherence assessment to highly active antiretroviral therapy.AIDS patient care and STDs, 15 3
H. Knobel, A. Carmona, S. Grau, J. Pedro-botet, A. Diez (1998)
Adherence and effectiveness of highly active antiretroviral therapy.Archives of internal medicine, 158 17
A. Wu, D. Revicki, D. Jacobson, F. Malitz (1997)
Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV)Quality of Life Research, 6
S. Call, J. Klapow, K. Stewart, A. Westfall, A. Mallinger, R. Demasi, R. Centor, M. Saag (2004)
Health-related Quality of Life and Virologic outcomes in an HIV ClinicQuality of Life Research, 9
A. Casado, E. Consiglio, D. Podzamczer, X. Badia (2001)
Highly Active Antiretroviral Treatment (HAART) and Health-Related Quality of Life in Naive and Pretreated HIV-Infected PatientsHIV Clinical Trials, 2
Hernando Knobel, I. Escobar, Rosa Polo, Luis Ortega, M.ª Martín-Conde, José Casado, C. Codina, J. Fernández, M.ª Galindo, Olatz Ibarra, Monserrat Llinas, C. Miralles, Melcior Riera, Carmina Fumaz, Aurea Segador, Ferrán Segura, Lourdes Chamorro (1999)
Recomendaciones GESIDA/SEFH/PNS para mejorar la adherencia al tratamiento antirretroviral en el año 2004Enfermedades Infecciosas Y Microbiologia Clinica, 23
X Badia, D Podzamczer, A Casado, C Lopez-Lavid, M. Garcia (2000)
Evaluating changes in health status in HIV-infected patients: Medical outcomes. Study-HIV and multidimensional quality of life-HIV quality of life questionnaires. Spanish MOS-HIV and MQOL-HIV Validation GroupAIDS, 14
Glenn Wagner, Judith Rabkin (2000)
Measuring medication adherence: Are missed doses reported more accurately than perfect adherence?AIDS Care, 12
A. Wu, H. Rubin, W. Mathews, J. Ware, Lucy Brysk, W. Hardy, S. Bozzette, S. Spector, D. Richman (1991)
A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study: Preliminary Validation in Persons With Early HIV InfectionMedical Care, 29
I. Marschner, A. Collier, R. Coombs, R. D’Aquila, V. DeGruttola, M. Fischl, S. Hammer, Michael Hughes, V. Johnson, D. Katzenstein, D. Richman, L. Smeaton, S. Spector, M. Saag (1998)
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy.The Journal of infectious diseases, 177 1
F. Altice, G. Friedland (1998)
The Era of Adherence to HIV TherapyAnnals of Internal Medicine, 129
C. Schag, P. Ganz, Barbara Kahn, L. Petersen (1992)
Assessing the needs and quality of life of patients with HIV infection: development of theHIVOverview ofProblems-EvaluationSystem (HOPES)Quality of Life Research, 1
B. Gazzard, G. Graeme (1998)
1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individualsThe Lancet, 352
N. Singh, C. Squier, C. Sivek, M. Wagener, M. Nguyen, V. Yu (1996)
Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance.AIDS care, 8 3
G. Lucas, R. Chaisson, R. Moore (1999)
Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug ReactionsAnnals of Internal Medicine, 131
A. Peterman, D. Cella, F. Mo, N. McCain (1997)
Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrumentQuality of Life Research, 6
D. Cella, N. McCain, A. Peterman, F. Mo, Deborah Wolen (1996)
Development and validation of the functional assessment of human immunodeficiency virus infection (FAHI) quality of life instrumentQuality of Life Research, 5
A. Gifford, J. Bormann, M. Shively, B. Wright, D. Richman, S. Bozzette (2000)
Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens.Journal of Acquired Immune Deficiency Syndromes, 23
Nina Singh, Steven Berman, S. Swindells, J. Justis, Jeffrey Mohr, C. Squier, M. Wagener (1999)
Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 29 4
S. Safren, S. Safren, M. Otto, J. Worth, Elizabeth Salomon, William Johnson, K. Mayer, Steve Boswell (2001)
Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring.Behaviour research and therapy, 39 10
M. Chesney (2000)
Factors affecting adherence to antiretroviral therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 30 Suppl 2
D. Bangsberg, F. Hecht, E. Charlebois, A. Zolopa, M. Holodniy, L. Sheiner, J. Bamberger, M. Chesney, A. Moss (2000)
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent populationAIDS, 14
K. Castro, J. Ward, L. Slutsker, J. Buehler, H. Jaffe, R. Berkelman, J. Curran (1993)
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 41 RR-17
J. Montaner, P. Reiss, D. Cooper, S. Vella, M. Harris, B. Conway, M. Wainberg, Richard Smith, P. Robinson, D. Hall, M. Myers, J. Lange (1998)
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.JAMA, 279 12
R. Murri, A. Ammassari, A. Luca, A. Cingolani, P. Marconi, Albert Wu, A. Antinori (2001)
Self-Reported Nonadherence with Antiretroviral Drugs Predicts Persistent ConditionHIV Clinical Trials, 2
R. Detels, A. Muñoz, G. McFarlane, L. Kingsley, J. Margolick, J. Giorgi, L. Schrager, J. Phair (1998)
Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.JAMA, 280 17
Bernardino Roca, Cayetano Gómez, Alberto Arnedo (2000)
Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients.The Journal of infection, 41 1
Kenneth Mayer, A. Angelino, G. Treisman (2001)
Management of psychiatric disorders in patients infected with human immunodeficiency virus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 33 6
J. McNabb, Jack Ross, Kenneth Abriola, C. Turley, C. Nightingale, David Nicolau (2001)
Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 33 5
P. Nieuwkerk, E. Gisolf, R. Colebunders, A. Wu, S. Danner, M. Sprangers (2000)
Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapyAIDS, 14
F. Hecht, R. Grant, C. Petropoulos, Beth Dillon, M. Chesney, H. Tian, N. Hellmann, Nirmala Bandrapalli, L. Digilio, B. Branson, J. Kahn (1998)
Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.The New England journal of medicine, 339 5
Michel Duong, L. Piroth, G. Peytavin, Fabien Forte, Evelyne Kohli, M. Grappin, M. Buisson, P. Chavanet, Henri Portier (2001)
Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 33 3
K. Maher, N. Klimas, Mary Fletcher, V. Cohen, C. Maggio, J. Triplett, R. Valenzuela, Gordon Dickinson (1999)
Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an Urban Veterans Affairs Medical Center.Journal of acquired immune deficiency syndromes, 22 4
R Detels, A Muñoz, G McFarlane (1998)
Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection durationJAMA, 280
C Pialoux, F Raffi, F Brun-Vezinet (1998)
A randomised trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patientsN Engl J Med, 339
Smith Kw, Avis Ne, K. Mayer, L. Swislow (1997)
Use of the MQoL-HIV with asymptomatic HIV-positive patientsQuality of Life Research, 6
JSG Montaner, P Reiss, D Cooper (1998)
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: The INCAS trialJAMA, 279
Objective: To investigate associations between health-related quality of life (HRQoL), as assessed using the multidimensional quality of life-HIV (MQOL-HIV) questionnaire, and adherence to antiretroviral treatment in HIV-infected subjects. Design: Multicentre cross-sectional study in three institutional tertiary hospitals in northwest Spain. Patients and methods: The MQOL-HIV was completed by 235 HIV-infected adults undergoing antiretroviral treatment. Adherence to antiretroviral therapy was assessed by using patient's self-report. Information about sociodemographic characteristics and clinical variables was also collected. Results: Good adherence (≥95% of prescribed pills correctly taken) was reported by 131 patients (55.7%). Univariate analyses indicated that the sociodemographic and clinical variables associated with adherence were age, educational level, income, employment, home stability, transmission route, history of previous antiretroviral therapy, and number of prescribed pills/day. Subscales of MQOL-HIV associated with adherence were mental health, cognitive functioning, financial status, medical care, partner intimacy, and (in men only) sexual functioning. Stepwise logistic regression showed that good adherence was more frequent in patients aged >40 years (odds ratio, OR: 2.50; 95% confidence interval, CI: 1.15–5.61) and in patients with high cognitive functioning (OR: 2.26; 95% CI: 1.19–4.30). Conversely, poor adherence was more frequent in patients without stable home (OR: 2.96; 95% CI: 1.39–6.32), in patients required to take 14 or more pills/day (OR: 2.17; 95% CI: 1.18–4.28), in patients with low financial status (OR: 3.42; 95% CI: 1.57–7.45), and in patients reporting low medical care (OR: 2.07; 95% CI: 1.07–3.98). Conclusions: HRQoL dimensions, notably cognitive functioning, financial status and medical care, are closely associated with antiretroviral therapy adherence.
Quality of Life Research – Springer Journals
Published: Oct 18, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.